Efficacy and safety of MAS825 (anti-IL-1β/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function
Hakim et al., Clinical and Experimental Immunology, doi:10.1093/cei/uxad065
https://c19early.org/hakim.html